Parkinson’s UK Award Targets New Therapies
Researchers at the Sheffield Institute for Translational Neuroscience (SITraN) have been awarded £1.2 million ($1.67 million) from Parkinson’s UK to…
Articles by Diana Campelo Delgado
Centogene Enrolls 10K in ROPAD Genetics Study
Centogene has completed enrollment of 10,000 participants in its two-year global study assessing the contribution of genetic factors in…
NeuroSphere Virtual Clinic Connects Patients to Doctors
Abbott has launched its NeuroSphere Virtual Clinic, a U.S. Food and Drug Administration (FDA)-approved digital technology that allows remote…
Playing Golf Might Be Even Better Than Tai Chi at Helping With Balance
Practicing golf may have more benefits than tai chi for improving mobility and balance in people with Parkinson’s disease, simply…
$1M Grant Adds Miami Site to PD GENEration Study
A $1-million grant has made it possible for the University of Miami Miller School of Medicine to be added to…
AbbVie, Mitokinin Partner to Advance PINK1 Program
AbbVie has purchased an exclusive right to acquire Mitokinin, which includes its PINK1 clinical program for the potential treatment…
Group Completes First Dose of Stem Cells for Bradykinesia
IMAC Holdings has completed dosing the first group of participants in a Phase 1 clinical trial evaluating its investigational…
Newronika’s AlphaDBS System Earns CE Mark in Europe
Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system being evaluated in patients with Parkinson’s disease, has…
Biogen, Sangamo to Develop Novel Gene Therapies
Biogen and Sangamo Therapeutics have begun a collaboration to develop and commercialize gene therapies for Parkinson’s and Alzheimer’s…
Cure Parkinson’s Grant Supports Potential Iron-trapping Treatment
Cure Parkinson’s is supporting AbFero Pharmaceuticals in its work to advance SP-420, a potential disease-modifying therapy for Parkinson’s disease that clears excess…